Phenocept Tablet 500 mg contains Mycophenolate Mofetil (MMF), an immunosuppressive medication primarily used to prevent organ rejection in patients undergoing kidney, heart, or liver transplantation. It is also prescribed for certain autoimmune conditions under specialist supervision.

Mycophenolate Mofetil works by selectively inhibiting lymphocyte proliferation, which plays a central role in the body’s immune response. By suppressing overactive immune activity, Phenocept helps prevent the body from attacking a transplanted organ, significantly reducing the risk of acute and chronic rejection. It can be used as part of a combination therapy, often with corticosteroids and calcineurin inhibitors, for optimal immunosuppression.

Phenocept 500 mg provides an effective oral dose for adult patients requiring long-term immunosuppressive therapy. The tablet formulation allows convenient administration, enabling consistent dosing to maintain stable blood levels of the drug and protect transplanted organs.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features

• Contains Mycophenolate Mofetil 500 mg per tablet

• Immunosuppressive therapy for organ transplant patients

• Prevents acute and chronic organ rejection

• Oral tablet for convenient administration

• Often used in combination with corticosteroids and calcineurin inhibitors

• Supports long-term graft survival and immune system management

Indications

Phenocept Tablet 500 mg is indicated for:

• Prevention of organ rejection: Following kidney, heart, or liver transplantation

• Autoimmune disorders (off-label): Certain autoimmune diseases as prescribed by a specialist

• Combination immunosuppressive therapy: Used alongside corticosteroids or calcineurin inhibitors to reduce immune-mediated organ damage

It is essential to use Phenocept under the supervision of a transplant physician or specialist to ensure safe and effective dosing.

Mechanism of Action

Mycophenolate Mofetil is converted in the body to mycophenolic acid (MPA), which inhibits inosine monophosphate dehydrogenase (IMPDH):

• IMPDH is essential for purine synthesis in lymphocytes

• Inhibition leads to reduced proliferation of T and B lymphocytes, the key mediators of organ rejection

• Does not significantly affect other cell types, providing selective immunosuppression

This targeted mechanism ensures effective prevention of graft rejection while minimizing broader immune suppression.

Dosage and Administration

• Typical adult dose: 500–1000 mg orally twice daily, as prescribed by a physician

• Take tablets on an empty stomach or at consistent times with water

• Dose adjustments may be required based on kidney function, liver function, and blood counts

• Regular monitoring of blood counts, kidney and liver function, and drug levels is essential

• Should be continued as directed to maintain immunosuppressive effect

Possible Side Effects

Common side effects:

• Nausea and vomiting

• Diarrhea

• Abdominal pain or discomfort

• Headache

• Mild infections due to immune suppression

Serious but rare side effects:

• Severe infections or sepsis

• Bone marrow suppression leading to anemia, leukopenia, or thrombocytopenia

• Liver or kidney function abnormalities

• Allergic reactions

Patients should report severe infections, unusual bleeding, or persistent gastrointestinal symptoms immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Use only under specialist supervision

• Avoid live vaccines during therapy

• Monitor blood counts and organ function regularly

• Inform your doctor of all medications to prevent drug interactions

• Pregnancy and breastfeeding require special consideration due to teratogenic risk

Storage Instructions

• Store in a cool, dry place below 25°C

• Protect from light and moisture

• Keep tablets in the original container, tightly closed

• Keep out of reach of children.